Rectal Cancer Global Clinical Trials Review, H2, 2013

GlobalData
November 30, 2013
131 Pages - SKU: GBDT5167364
Clinical Trails Market in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
Clinical Trails Market in India - 2014 This report provides an insight into the Clinical Trails current market scenario, structure and practices in India. In depth market scenario includes; Market estimate of Clinical Trails in India for FY14 Share  |  read more...
USD 4,000
Malignant Melanoma: KOL Insight
10/17/2014 | published by: FirstWord
Introduction Malignant Melanoma: PD-1 inhibitors revolutionise treatment is a comprehensive report with insights from 12 leading US and European KOLs offering their latest views on current and late-stage pipeline products, why and  |  read more...
USD 6,495
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023
11/1/2014 | published by: GlobalData
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune destruction  |  read more...
USD 3,995
EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023
10/27/2014 | published by: GlobalData
EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023 Summary Cushing’s syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, such as cortisol. Cortisol is a hormone produced by  |  read more...
USD 3,995
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023
10/27/2014 | published by: GlobalData
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023 Summary Irritable Bowel Syndrome (IBS) is a chronic, relapsing gastrointestinal disorder that is characterized by abdominal discomfort or pain, bloating, and changes in bowel habit. Due to  |  read more...
USD 3,995
Ovarian Cancer - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Ovarian Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ovarian  |  read more...
USD 2,500
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2014’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)’s  |  read more...
USD 2,000
Sarcopenia - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Sarcopenia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H2 2014’, provides an overview of the Sarcopenia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sarcopenia, complete with comparative  |  read more...
USD 2,000
Contact Dermatitis - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Contact Dermatitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Contact Dermatitis - Pipeline Review, H2 2014’, provides an overview of the Contact Dermatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contact  |  read more...
USD 2,000
Alcoholic Hepatitis - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Alcoholic Hepatitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Alcoholic Hepatitis - Pipeline Review, H2 2014’, provides an overview of the Alcoholic Hepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcoholic  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 2,500  
    Site License  USD 5,000  
    Global Site License  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!